
A study on hypertrophic cardiomyopathy (HCM) has identified differences in the behavior of two sarcomere genes associated with the condition. The genes, MYBPC3 and MYH7, were found to have distinct impacts on myocardial performance and left ventricular (LV) function over time. Results showed that MYBPC3 patients had a higher prevalence of severe LV systolic dysfunction and a greater decline in LV systolic function than MYH7 patients.
Like
Save
Share